ConductScience.org, home

Paper7650366

Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.

D'Andrea A and 5 others. J Immunol, 1995. Cited by 296 papers, by iCite.

Cite this record

ConductScience Library. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. Papers, record 7650366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7650366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
PubMed
Journal
J Immunol
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
296
iCite
Relative citation ratio, by iCite
5.49
iCite
Revised in PubMed
2007-11-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Andrea AA
2Chang CC
3Franz-Bacon KK
4McClanahan TT
5Phillips JHJ H
6Lanier LLL L

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cloning, MolecularMajor topic
DNA, ComplementaryMajor topic
HLA-B AntigensMajor topic
Receptors, ImmunologicMajor topic
Amino Acid Sequence
Base Sequence
Blotting, Southern
Chromosome Mapping
Clone Cells
Gene Expression
Humans
Killer Cells, Natural
Molecular Sequence Data
RNA, Messenger
Receptors, KIR
Receptors, KIR2DL3
Receptors, KIR3DL1
Receptors, KIR3DS1
T-Lymphocytes

Source PubMed

Download CSV of topics

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 296 citations.

PMIDTitleJournalYearIn PapersSource
40660312Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.Stem Cell Res Ther2025https://conductscience.org/library/papers/40660312PubMed
40246292Natural killer cell-based immunotherapy for cancer.J Immunol2025https://conductscience.org/library/papers/40246292PubMed
39511139Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39511139PubMed
38842526Five decades of natural killer cell discovery.J Exp Med2024https://conductscience.org/library/papers/38842526PubMed
38202265Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans.J Clin Med2024https://conductscience.org/library/papers/38202265PubMed
37454198Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.Sci Rep2023https://conductscience.org/library/papers/37454198PubMed
34583856Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.Hum Immunol2022https://conductscience.org/library/papers/34583856PubMed
33049053HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.Blood Adv2020https://conductscience.org/library/papers/33049053PubMed
32655581Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.Front Immunol2020https://conductscience.org/library/papers/32655581PubMed
32211339N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion.Front Cell Infect Microbiol2020https://conductscience.org/library/papers/32211339PubMed
31231370Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.Front Immunol2019https://conductscience.org/library/papers/31231370PubMed
26938992A vision of KIR variation at super resolution.Immunology2016https://conductscience.org/library/papers/26938992PubMed
26037048The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.Curr Top Microbiol Immunol2016https://conductscience.org/library/papers/26037048PubMed
26029215Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Front Immunol2015https://conductscience.org/library/papers/26029215PubMed
26013798Practical NK cell phenotyping and variability in healthy adults.Immunol Res2015https://conductscience.org/library/papers/26013798PubMed
25374665Natural killer cell regulation - beyond the receptors.F1000Prime Rep2014https://conductscience.org/library/papers/25374665PubMed
25253288Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients.Genes Immun2014https://conductscience.org/library/papers/25253288PubMed
24856895Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.Cytotherapy2014https://conductscience.org/library/papers/24856895PubMed
24672522Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies.Front Immunol2014https://conductscience.org/library/papers/24672522PubMed
24517425The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).Immunol Rev2014https://conductscience.org/library/papers/24517425PubMed

See all 84 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KIR3DL13811Swiss-Prot's referenceshttps://conductscience.org/library/genes/3811NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
KIR2DL33804PubTator's text mininghttps://conductscience.org/library/genes/3804NCBI Gene

Download CSV of genes

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKU31416GENBANK
GENBANKU33328GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7650366

GET https://conductscience.org/api/papers/v1/7650366/cited_by?page=2